“Biotechnology and the industries it will enable in the future are a key part of Queensland’s economic prosperity. Agriculture, energy and mining, biomedical, environmental and industrial sectors all to some extent will draw on the innovative potential of biotechnology. Life Sciences Queensland will bring together the relevant players to make a contribution to the diversification and strengthening of Queensland and Australia’s future”
Dr Peter Riddles – Inaugural Chairman
Life Sciences Queensland Limited (LSQ) is an Australian Peak Body who offers opportunities for industry stakeholders to come together and cooperate to grow their businesses and help create a dynamic, internationally competitive and sustainable life sciences industry in Queensland, Australia. LSQ is helping to shape the strategic direction of the industry in the State and influence public policy. LSQ also provides Members with tools, services, market intelligence and access to an international network of life sciences organisations with the aim of identifying new business opportunities and accelerating business growth.
In a broader sense, LSQ is working to enhance Queensland’s national and international reputation as a centre of commercial and research excellence in life sciences by creating one voice for the industry to promote and support all segments of the Queensland life sciences industry, an industry which works to heal, feed and fuel our citizens.
LSQ engages the full spectrum of the Queensland life sciences industry, to assist the growth of individual organisations and industry segments, and to build the profile, capacity and capability of the sector to help ensure long term economic, social and environmental benefits to Queensland and its Members. The primary objectives of LSQ are to:
- Develop the industry by supporting local industry forums and providing Members with tools to accelerate their business growth.
- Create new business opportunities for Members through market outreach (e.g. business development services, event management, a coordinated approach to international business meetings) that Members cannot readily or cost-effectively achieve on their own.
- Play a leading role in influencing public policy so as to help ensure sustainable growth of the Queensland Life Science Industry.
Sub-sectors that are illustrative of the Australian life science industry include:
- Human Healthcare (pharmaceuticals or drug discovery, complementary medicines, functional foods/beverages, medical devices and diagnostics),
- Animal Health,
- Agricultural and Environmental Biotechnology,
- Marine Biotechnology and
- Industrial Biotechnology, including Bio-mining and Bio-energy.
Prof Peter Andrews AO - Chairman
Professor Andrews served as Queensland's first Chief Scientist from 2003 to 2010. Before that, he led multidisciplinary scientific teams in several Australian universities and co-founded six biotechnology companies, two of which took drugs to global markets.
He is the co-author, with social scientist Dr Fiona Wood, of "Überpreneurs: how to create innovative global businesses and transform human societies", published in 2014.
He is currently chairman of the boards of Implicit Bioscience Ltd, Vast Bioscience Pty Ltd and QUTbluebox Pty Ltd, and of the scientific advisory boards of Bond University Faculty of Health Sciences and Medicine and the Maurice Wilkins Centre for Molecular Biodiscovery (NZ).
Jennifer Barker - EY
Jennifer is an Assurance Director in EY’s Brisbane office and has over fourteen years’ experience in auditing a variety of industries and corporate reporting requirements in Australia and the United States. Jennifer joined EY in 2002 in the Raleigh USA office and then transferred to the Brisbane office in 2006.
She has had a broad range of experience serving clients in a variety of industries including waste management, pharmaceutical, technology, and diversified products.
David Camerlengo - Austrade
David Camerlengo is Head of Advanced Technology - Centre of Excellence at Austrade. Previously, as the Director of SEED Strategies, David has helped governments and industry across Australia achieve local economic impact through innovation, investment and international trade. Through SEED Strategies, David also consulted to the Queensland Government (Queensland Treasury) supporting the development of a Trade & Enterprise spine under the SEQ City Deal.
David was also General Manager of Unearthed in Brisbane, supporting corporates to advance their innovation agenda and creating the future of work through open-innovation to transform the resources industry. Prior to this, David was Trade & Investment Commissioner to North America for the Queensland government, leading the state’s engagement in the region to drive economic impact in Queensland.
David is passionate about Australia’s entrepreneurs and represented Queensland on the board of the Open Worldwide Innovation Network (OWIN) to create global pathways for Queensland companies. He was also a board member of the Australian American Chamber of Commerce in the USA.
David holds a Master of Science in Technology Commercialisation (MSTC) from the University of Texas–Austin and a Bachelor of Mechanical Engineering (B.ME) from Queensland University of Technology (QUT).
Prof Bronwyn Harch - University of Queensland
As Deputy Vice-Chancellor (Research) and Vice-President (Research), Professor Harch is responsible for enhancing the University’s performance and reputation in research, research training, and research collaboration with external stakeholders, nationally and internationally.
Professor Bronwyn Harch is an applied statistician with 22 years experience leading and undertaking research focused at the nexus of agricultural and environmental systems. She is passionate about making an impact by generating knowledge, technology and practices that make our world more sustainable, secure and resilient.
Before joining UQ in July 2018, Professor Harch was Executive Director of the Institute for Future Environments at Queensland University of Technology (QUT). She was also the establishment Research Director of the Australian Government Cooperative Research Centre on ‘Food Agility’ – a transdisciplinary partnership with industry aimed at growing the agrifood sector’s comparative advantage through digital transformation. Prior to joining QUT in 2014, Professor Harch worked for 18 years as a researcher and research strategist at the Commonwealth Scientific and Industrial Research Organisation (CSIRO).
Sarah Meibusch - OneVentures
Sarah Meibusch is a motivated, high achieving life science leader based in Brisbane, Australia. She is currently a Principal at one of Australia’s largest venture capital firms, OneVentures. In this role, she is responsible for sourcing life sciences companies and actively shaping their future. She applies her global executional experience and entrepreneurial passion to nurture their success. Her enterprise level leadership experience has been forged over 20 years in a wide spectrum of organisations, including start-up, private companies, ASX and NASDAQ-listed companies, a multi-national pharmaceutical company and university research organisations.
Prior to OneVentures, she was the Asian Business Development lead for Shire Pharmaceuticals (now Takeda), a global specialty pharmaceutical company. Sarah identified technologies and developed collaborations across Japan, Korea, Australia, New Zealand, Singapore and Taiwan including playing a key role in sourcing the $300M Fibrotech deal announced in 2015. Sarah has a strong operational understanding of the pharmaceutical and life science industries gained through senior management roles at the Progen Pharmaceuticals, The University of Queensland’s QAAFI institute, Beef CRC and Pyxis Genomics.
Sarah is a graduate of the Australian Institute of Company Directors (GAICD) and currently holds directorships with Kira Biotech, QAAFI Advisory Board and Life Sciences Queensland. She holds Bachelor level science qualifications from the University of Queensland and a Masters from Cornell University and has completed a postgraduate course at Harvard Business School focusing on negotiation and decision making.
Prof Sagadevan G. Mundree - Centre for Tropical Crops and Biocommodities, Institute for Future Environments, Queensland University of Technology
Sagadevan Mundree was appointed Director of the Centre for Tropical Crops and Biocommodities (CTCB) at Queensland University of Technology in January 2016. Prior to that, Sagadevan was Deputy Director of the CTCB for 5 years. He leads a research Team that is focused on making crops more resilient to environmental stresses such as drought and salinity and more nutritious. Prior to joining QUT, he was a Senior Executive in the Queensland Department of Primary Industries and Fisheries (QPIF) where he led a Team that was responsible for QPIF’s Investments in Research, Development and Extension in all the primary industries of Queensland. Sagadevan is a former academic from the University of Cape Town and served as Chief Executive Officer of South Africa’s National Innovation Centre for Agricultural Biotechnology. He holds a PhD in Molecular and Cell Biology, which he completed at Auburn University (USA) on a Fulbright Scholarship, an MBA from the University of Cape Town and recently became a Senior Executive Fellow of the Harvard Kennedy School. Sagadevan is a member of the South African Academy of Science and served on the National Biotechnology Advisory Council.
Distinguished Prof Louis Schofield - Australian Institute of Tropical Health and Medicine (AITHM) and the Queensland Tropical Health Alliance (QTHA), James Cook University
Distinguished Professor Schofield is inaugural Director of the Australian Institute of Tropical Health and Medicine (AITHM) and the Queensland Tropical Health Alliance (QTHA). He was for 24 years an NH&MRC Research Fellow at the Walter and Eliza Hall Institute in Melbourne, has twice held an International Research Scholarship of the Howard Hughes Medical Institute, and was co-founder of Ancora Pharmaceuticals Inc.
A recognised authority in the immunology and pathogenesis of infectious diseases, his research programs cover basic molecular sciences, product development and commercialisation, epidemiology and public health. His approach to malaria has resulted in promising vaccine development programs, and clinical trials in Papua New Guinea and Africa. He has published key articles in the highest ranked international journals and received over 6,500 citations to date.
Mrs. Clare Blain - Chief Executive Officer
Clare Blain has worked with Life Sciences Queensland (LSQ) since its inception in 2011 and now represents the organisation’s Members in her role as Chief Executive Officer.
Previously Chief Operating Officer and Operations Manager at LSQ, Clare is passionate about highlighting the integral role life science innovation plays in Queensland’s diverse economy.
Prior to joining LSQ, Clare was Marketing Manager at Queensland Clinical Trials Network where she played a key role in positioning the organisation as the primary point of contact for preclinical and clinical research in Australia. As a result, she successfully identified and connected a range of sponsors with members, including research institutions, hospitals, clinical research organisations and other life science service providers.
Clare also spent three years working with Master Builders Queensland where she gained valuable insights into membership bodies and the construction industry.
Through her work at LSQ, Clare hopes to raise the profile of the life sciences sector on the world stage to help bring long-term economic, social and environmental benefits to Queenslanders.
Dr Nagaraj Gopisetty - Deputy Chief Executive Officer, B. Pharm, MSc (Hons) Biotechnology, PhD, MBA
Dr Nagaraj Gopisetty is the Deputy CEO of Life Sciences Queensland and will be heading the business development arm for LSQ - The Life Sciences Catalyst. The program will be a launching pad delivering targeted initiatives that will help advance innovations and accelerate the growth of Queensland's knowledge-based life sciences industry.
Prior to joining LSQ, Nagaraj was the Business Development and Innovation Education Manager at the Translational Research Institute. He has been working as an innovation champion with a proven track record in technology commercialisation. Nagaraj has experience in facilitating partnerships between academia and industry, bringing together key stakeholders and capabilities enabling effective pathways for translation and commercialisation. He has scientific and business insights with advanced knowledge and effective skills in intellectual property management, contract and licence negotiations, projects and portfolio management, alliance management, research and business development, capital raising, strategy implementation, sales and marketing.
Nagaraj holds a BPharm degree from India, a Masters in Biotechnology (Hon’s) degree from Griffith University and a PhD in Pharmacy from the University of Queensland. More recently, he has earned an MBA from the University of Newcastle.
Nagaraj is passionately interested in improving practices and processes within the knowledge exchange and knowledge transfer activities relevant to translation and entrepreneurship in the life sciences sector.
Lachlan Storie - Stakeholder Engagement
Lachlan Storie leads LSQ's Stakeholder Engagement with a focus on delivering value for Members. He joined LSQ in 2015, previously working in membership for the Queensland Reds. Lachlan holds a Bachelor of Business Management (UQ) and has a comprehensive background in agriculture, hailing from rural NSW.